Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Human PLAUR ELISA Kit for Sandwich ELISA - ABIN414932
Russo: Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism. in Biomarker insights 2013
Show all 5 Pubmed References
Mouse (Murine) PLAUR ELISA Kit for Sandwich ELISA - ABIN415603
Yan, DeMars: Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice. in International journal of cancer. Journal international du cancer 2012
Human PLAUR ELISA Kit for Sandwich ELISA - ABIN2685207
Memarzadeh, Kozak, Chang, Natarajan, Shintaku, Reddy, Farias-Eisner, Memarzedeh: Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer. in Proceedings of the National Academy of Sciences of the United States of America 2002
Show all 3 Pubmed References
Plg-RKT is required for plasminogen (show PLG ELISA Kits) binding and macrophage migration in vivo
The synergy of circulating factor suPAR and APOL1 (show APOL1 ELISA Kits) G1 or G2 on alphavbeta3 integrin activation is a mechanism for CKD.
Results identify soluble uPAR as a functional connection between the bone marrow and the kidney, and they implicate bone marrow immature myeloid cells as a key source of soluble uPAR that leads to glomerular dysfunction.
Plaur deficiency does not increase susceptibility to epileptogenesis after traumatic brain injury in an animal model.
Significance of the urokinase-type plasminogen activator (show PLAU ELISA Kits) and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models.
Findings indicate a significant correlation of uPAR cleavage with breast cancer progression, but the precise biological consequence(s) of the cleavage or the cleavage products still remains to be elucidated.
interaction of full-length suPAR with alphavbeta3 integrin expressed on podocytes results in down-modulation of nephrin (show NPHS1 ELISA Kits) that may affect kidney functionality in different human pathologies characterized by increased concentration of suPAR.
In an in vivo murine angiogenesis model uPAR-deficient PTEN heterozygous animals increased the impaired angiogenic phenotype of uPAR knockout mice and were able to reverse the high invasive potential of PTEN heterozygotes.
uPAR contributes to macrophage driven atherosclerotic lesion formation.
we have firstly shown a fundamental mechanism of urokinase system(uPa (show PLAU ELISA Kits) and uPAR)-dependent regulation of the trajectory of growth and branching of blood vessels in early embryogenesis and in adults during the repair/regeneration of tissues.
Two interacting partners of urokinase-type plasminogen activator (uPA) receptor, the cysteine-rich angiogenic inducer 61 (Cyr61 (show CYR61 ELISA Kits)) and the Y-box-binding protein 1 (YB-1 (show YBX1 ELISA Kits)) were identified and their differential expression demonstrated in the triple-negative breast cancer (TNBC) cells as well as in tumors.
Study provides evidence that the stimulation of u-PA (show PLAU ELISA Kits)/u-PAR system contributes to the activated phenotype and function of cancer-associated fibroblasts during multiple myeloma.
Binding of uPAR to VN triggers integrin-mediated signals, which result in ERK1-2 (show MAPK1/3 ELISA Kits) and RAC (show AKT1 ELISA Kits) activation, accumulation of ROS (show ROS1 ELISA Kits), and senescence.
Plasma levels of intact and cleaved urokinase plasminogen activator receptor do not hold important predictive or prognostic information in men with clinically localised prostate cancer.
This study provides novel data that elevated airway and blood uPAR is a feature of asthma and that blood uPAR is particularly related to severe, nonatopic asthma.
Moesin (show MSN ELISA Kits) and merlin (show NF2 ELISA Kits) regulate urokinase receptor-dependent endothelial cell migration, adhesion and angiogenesis
uPAR and mTORC2 (show CRTC2 ELISA Kits) are components of a single cell-signaling pathway.
Results provide evidence that uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA (show PRAP1 ELISA Kits) and IGF1R (show IGF1R ELISA Kits).
PLAUR to be essential for activation of Checkpoint kinase 1 (CHK1 (show CHEK1 ELISA Kits)); maintenance of cell cycle arrest after DNA damage in a TP53 (show TP53 ELISA Kits)-dependent manner; expression, nuclear import and recruitment to DNA-damage foci of RAD51 (show RAD51 ELISA Kits) recombinase (show RAG1 ELISA Kits), the principal protein involved in the homologous recombination repair pathway.
Data show that urokinase-type plasminogen activator (uPA (show PLAU ELISA Kits)) is only expressed in the cumulus cells of immature and in vitro matured cumulus-oocyte complexes (COCs), while uPA (show PLAU ELISA Kits) receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1 (show SERPINE1 ELISA Kits)) are expressed in both the cumulus cells and the immature and in vitro matured oocytes.
uPA (show PLAU ELISA Kits)/uPAR binding is involved in signaling pathways that activate transcription factors that regulate the synthesis of molecules concerned with the arrangement of a particular oviductal microenvironment.
Data indicate that superoxide dismutase (SOD) inhibited high glucose (HG)-induced expression of uPAR and VEGF in bovine retinal microvascular endothelial cell (REC).
These data indicated that E. coli LPS (show IRF6 ELISA Kits) led to an increase in u-PA (show PLAU ELISA Kits) activity and RNA expression of u-PA (show PLAU ELISA Kits) and u-PAR in BME-UV1 cells, thus strengthening the role of the PA system during pathological processes.
the interaction between uPAR and Man-6-P/IGF2R (show IGF2R ELISA Kits) is a low percentage binding event and that suPAR and full-length uPAR bind the Man-6-P/IGF2R (show IGF2R ELISA Kits) by different mechanisms.
This gene encodes the receptor for urokinase plasminogen activator and, given its role in localizing and promoting plasmin formation, likely influences many normal and pathological processes related to cell-surface plasminogen activation and localized degradation of the extracellular matrix. It binds both the proprotein and mature forms of urokinase plasminogen activator and permits the activation of the receptor-bound pro-enzyme by plasmin. The protein lacks transmembrane or cytoplasmic domains and may be anchored to the plasma membrane by a glycosyl-phosphatidylinositol (GPI) moiety following cleavage of the nascent polypeptide near its carboxy-terminus. However, a soluble protein is also produced in some cell types. Alternative splicing results in multiple transcript variants encoding different isoforms. The proprotein experiences several post-translational cleavage reactions that have not yet been fully defined.
urokinase plasminogen activator surface receptor
, plasminogen activator, urokinase receptor
, urokinase plasminogen activator receptor
, urokinase-type plasminogen activator receptor
, monocyte activation antigen Mo3
, u-plasminogen activator receptor form 2
, urokinase-type plasminogen activator (uPA) receptor
, plasminogen activator urokinase receptor 3
, urinary plasminogen activator receptor 2
, urinary plasminogen activator receptor 3